Cite
Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter.
MLA
Trifan, Anca, et al. “Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter.” Journal of Clinical Medicine, vol. 11, no. 19, Oct. 2022, p. 5959. EBSCOhost, https://doi.org/10.3390/jcm11195959.
APA
Trifan, A., Stafie, R., Rotaru, A., Stratina, E., Zenovia, S., Nastasa, R., Huiban, L., Cuciureanu, T., Muzica, C., Chiriac, S., Girleanu, I., Singeap, A.-M., Sfarti, C., Cojocariu, C., Petrea, O., & Stanciu, C. (2022). Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter. Journal of Clinical Medicine, 11(19), 5959. https://doi.org/10.3390/jcm11195959
Chicago
Trifan, Anca, Remus Stafie, Adrian Rotaru, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Laura Huiban, et al. 2022. “Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter.” Journal of Clinical Medicine 11 (19): 5959. doi:10.3390/jcm11195959.